These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9884086)

  • 1. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.
    Valjent E; Maldonado R
    Psychopharmacology (Berl); 2000 Jan; 147(4):436-8. PubMed ID: 10672638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
    Balerio GN; Aso E; Berrendero F; Murtra P; Maldonado R
    Eur J Neurosci; 2004 Nov; 20(10):2737-48. PubMed ID: 15548217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
    Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
    J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.
    Castañé A; Maldonado R; Valverde O
    Br J Pharmacol; 2004 Aug; 142(8):1309-17. PubMed ID: 15265804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
    Tai S; Nikas SP; Shukla VG; Vemuri K; Makriyannis A; Järbe TU
    Psychopharmacology (Berl); 2015 Aug; 232(15):2751-61. PubMed ID: 25772338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
    McMahon LR; France CP
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1290-5. PubMed ID: 8819514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
    Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
    Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential disruption of response alternation by precipitated Δ
    Eckard ML; Kinsey SG
    Pharmacol Biochem Behav; 2024 Mar; 236():173718. PubMed ID: 38272272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum.
    Tzavara ET; Valjent E; Firmo C; Mas M; Beslot F; Defer N; Roques BP; Hanoune J; Maldonado R
    Eur J Neurosci; 2000 Mar; 12(3):1038-46. PubMed ID: 10762335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
    Cook SA; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.
    Tsou K; Patrick SL; Walker JM
    Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
    Huang P; Liu-Chen LY; Unterwald EM; Cowan A
    Neurosci Lett; 2009 Nov; 465(1):66-70. PubMed ID: 19733208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
    Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
    Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.
    Mas-Nieto M; Pommier B; Tzavara ET; Caneparo A; Da Nascimento S; Le Fur G; Roques BP; Noble F
    Br J Pharmacol; 2001 Apr; 132(8):1809-16. PubMed ID: 11309253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.